Logo image of HBI

HANESBRANDS INC (HBI) Stock Fundamental Analysis

NYSE:HBI - US4103451021 - Common Stock

6.275 USD
+0.04 (+0.56%)
Last: 8/26/2025, 11:16:49 AM
Fundamental Rating

4

Taking everything into account, HBI scores 4 out of 10 in our fundamental rating. HBI was compared to 50 industry peers in the Textiles, Apparel & Luxury Goods industry. HBI has a medium profitability rating, but doesn't score so well on its financial health evaluation. HBI is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

HBI had positive earnings in the past year.
In the past year HBI had a positive cash flow from operations.
In the past 5 years HBI reported 4 times negative net income.
Of the past 5 years HBI 4 years had a positive operating cash flow.
HBI Yearly Net Income VS EBIT VS OCF VS FCFHBI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

1.2 Ratios

The Return On Assets of HBI (2.22%) is comparable to the rest of the industry.
The Return On Equity of HBI (53.63%) is better than 100.00% of its industry peers.
With an excellent Return On Invested Capital value of 13.28%, HBI belongs to the best of the industry, outperforming 82.00% of the companies in the same industry.
HBI had an Average Return On Invested Capital over the past 3 years of 9.25%. This is in line with the industry average of 10.66%.
The 3 year average ROIC (9.25%) for HBI is below the current ROIC(13.28%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.22%
ROE 53.63%
ROIC 13.28%
ROA(3y)-3.54%
ROA(5y)-2.1%
ROE(3y)-326.11%
ROE(5y)-195.33%
ROIC(3y)9.25%
ROIC(5y)10.86%
HBI Yearly ROA, ROE, ROICHBI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

HBI has a Profit Margin (2.56%) which is comparable to the rest of the industry.
With an excellent Operating Margin value of 13.47%, HBI belongs to the best of the industry, outperforming 82.00% of the companies in the same industry.
HBI's Operating Margin has declined in the last couple of years.
HBI's Gross Margin of 42.19% is on the low side compared to the rest of the industry. HBI is outperformed by 64.00% of its industry peers.
HBI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.47%
PM (TTM) 2.56%
GM 42.19%
OM growth 3Y-4.92%
OM growth 5Y-3.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y1.34%
HBI Yearly Profit, Operating, Gross MarginsHBI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), HBI is creating some value.
Compared to 1 year ago, HBI has more shares outstanding
HBI has less shares outstanding than it did 5 years ago.
HBI has a worse debt/assets ratio than last year.
HBI Yearly Shares OutstandingHBI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
HBI Yearly Total Debt VS Total AssetsHBI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 1.89 indicates that HBI is not a great score, but indicates only limited risk for bankruptcy at the moment.
HBI has a Altman-Z score of 1.89. This is in the lower half of the industry: HBI underperforms 76.00% of its industry peers.
HBI has a debt to FCF ratio of 41.06. This is a negative value and a sign of low solvency as HBI would need 41.06 years to pay back of all of its debts.
HBI's Debt to FCF ratio of 41.06 is on the low side compared to the rest of the industry. HBI is outperformed by 64.00% of its industry peers.
A Debt/Equity ratio of 13.62 is on the high side and indicates that HBI has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 13.62, HBI is doing worse than 88.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 13.62
Debt/FCF 41.06
Altman-Z 1.89
ROIC/WACC1.31
WACC10.17%
HBI Yearly LT Debt VS Equity VS FCFHBI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.52 indicates that HBI should not have too much problems paying its short term obligations.
HBI has a Current ratio of 1.52. This is in the lower half of the industry: HBI underperforms 72.00% of its industry peers.
HBI has a Quick Ratio of 1.52. This is a bad value and indicates that HBI is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of HBI (0.74) is worse than 74.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 0.74
HBI Yearly Current Assets VS Current LiabilitesHBI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 142.31% over the past year.
Measured over the past years, HBI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -23.96% on average per year.
Looking at the last year, HBI shows a very negative growth in Revenue. The Revenue has decreased by -23.93% in the last year.
Measured over the past years, HBI shows a very negative growth in Revenue. The Revenue has been decreasing by -11.40% on average per year.
EPS 1Y (TTM)142.31%
EPS 3Y-37.35%
EPS 5Y-23.96%
EPS Q2Q%60%
Revenue 1Y (TTM)-23.93%
Revenue growth 3Y-19.81%
Revenue growth 5Y-11.4%
Sales Q2Q%-0.41%

3.2 Future

HBI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.06% yearly.
Based on estimates for the next years, HBI will show a small growth in Revenue. The Revenue will grow by 0.83% on average per year.
EPS Next Y48.77%
EPS Next 2Y22.64%
EPS Next 3Y17.53%
EPS Next 5Y14.06%
Revenue Next Year-2.25%
Revenue Next 2Y-1.67%
Revenue Next 3Y-0.89%
Revenue Next 5Y0.83%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HBI Yearly Revenue VS EstimatesHBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
HBI Yearly EPS VS EstimatesHBI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0.5 1 1.5

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 9.96, the valuation of HBI can be described as very reasonable.
Based on the Price/Earnings ratio, HBI is valued cheaply inside the industry as 84.00% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of HBI to the average of the S&P500 Index (27.03), we can say HBI is valued rather cheaply.
The Price/Forward Earnings ratio is 9.27, which indicates a very decent valuation of HBI.
88.00% of the companies in the same industry are more expensive than HBI, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of HBI to the average of the S&P500 Index (22.63), we can say HBI is valued rather cheaply.
Industry RankSector Rank
PE 9.96
Fwd PE 9.27
HBI Price Earnings VS Forward Price EarningsHBI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HBI indicates a somewhat cheap valuation: HBI is cheaper than 62.00% of the companies listed in the same industry.
HBI's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 38.49
EV/EBITDA 8.24
HBI Per share dataHBI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as HBI's earnings are expected to grow with 17.53% in the coming years.
PEG (NY)0.2
PEG (5Y)N/A
EPS Next 2Y22.64%
EPS Next 3Y17.53%

More info and screens

0

5. Dividend

5.1 Amount

HBI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HANESBRANDS INC

NYSE:HBI (8/26/2025, 11:16:49 AM)

6.275

+0.04 (+0.56%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-05 2025-11-05/bmo
Inst Owners93.15%
Inst Owner Change1.92%
Ins Owners1.12%
Ins Owner Change6.37%
Market Cap2.22B
Analysts50.77
Price Target5.95 (-5.18%)
Short Float %10.88%
Short Ratio4.64
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)125.71%
Min EPS beat(2)33.5%
Max EPS beat(2)217.92%
EPS beat(4)4
Avg EPS beat(4)73.29%
Min EPS beat(4)17.38%
Max EPS beat(4)217.92%
EPS beat(8)6
Avg EPS beat(8)43.31%
EPS beat(12)9
Avg EPS beat(12)34.6%
EPS beat(16)11
Avg EPS beat(16)27.01%
Revenue beat(2)2
Avg Revenue beat(2)0.62%
Min Revenue beat(2)0.05%
Max Revenue beat(2)1.19%
Revenue beat(4)2
Avg Revenue beat(4)-3.69%
Min Revenue beat(4)-8.58%
Max Revenue beat(4)1.19%
Revenue beat(8)2
Avg Revenue beat(8)-6.83%
Revenue beat(12)3
Avg Revenue beat(12)-4.9%
Revenue beat(16)4
Avg Revenue beat(16)-4.45%
PT rev (1m)7.94%
PT rev (3m)18.95%
EPS NQ rev (1m)12.4%
EPS NQ rev (3m)2.93%
EPS NY rev (1m)22.22%
EPS NY rev (3m)22.22%
Revenue NQ rev (1m)0.4%
Revenue NQ rev (3m)-0.69%
Revenue NY rev (1m)1.11%
Revenue NY rev (3m)1.02%
Valuation
Industry RankSector Rank
PE 9.96
Fwd PE 9.27
P/S 0.64
P/FCF 38.49
P/OCF 25.29
P/B 13.34
P/tB N/A
EV/EBITDA 8.24
EPS(TTM)0.63
EY10.04%
EPS(NY)0.68
Fwd EY10.79%
FCF(TTM)0.16
FCFY2.6%
OCF(TTM)0.25
OCFY3.95%
SpS9.85
BVpS0.47
TBVpS-3.94
PEG (NY)0.2
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.22%
ROE 53.63%
ROCE 16.81%
ROIC 13.28%
ROICexc 14.42%
ROICexgc 36.61%
OM 13.47%
PM (TTM) 2.56%
GM 42.19%
FCFM 1.65%
ROA(3y)-3.54%
ROA(5y)-2.1%
ROE(3y)-326.11%
ROE(5y)-195.33%
ROIC(3y)9.25%
ROIC(5y)10.86%
ROICexc(3y)9.89%
ROICexc(5y)12.07%
ROICexgc(3y)24.54%
ROICexgc(5y)28.18%
ROCE(3y)11.7%
ROCE(5y)13.75%
ROICexcg growth 3Y-1.22%
ROICexcg growth 5Y5.88%
ROICexc growth 3Y-7.77%
ROICexc growth 5Y0.09%
OM growth 3Y-4.92%
OM growth 5Y-3.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y1.34%
F-Score7
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 13.62
Debt/FCF 41.06
Debt/EBITDA 4.29
Cap/Depr 51.19%
Cap/Sales 0.86%
Interest Coverage 250
Cash Conversion 16.62%
Profit Quality 64.63%
Current Ratio 1.52
Quick Ratio 0.74
Altman-Z 1.89
F-Score7
WACC10.17%
ROIC/WACC1.31
Cap/Depr(3y)95.15%
Cap/Depr(5y)77.33%
Cap/Sales(3y)1.91%
Cap/Sales(5y)1.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)142.31%
EPS 3Y-37.35%
EPS 5Y-23.96%
EPS Q2Q%60%
EPS Next Y48.77%
EPS Next 2Y22.64%
EPS Next 3Y17.53%
EPS Next 5Y14.06%
Revenue 1Y (TTM)-23.93%
Revenue growth 3Y-19.81%
Revenue growth 5Y-11.4%
Sales Q2Q%-0.41%
Revenue Next Year-2.25%
Revenue Next 2Y-1.67%
Revenue Next 3Y-0.89%
Revenue Next 5Y0.83%
EBIT growth 1Y8.16%
EBIT growth 3Y-23.76%
EBIT growth 5Y-14.59%
EBIT Next Year26.31%
EBIT Next 3Y9.48%
EBIT Next 5Y8.7%
FCF growth 1Y-45.95%
FCF growth 3Y-25.8%
FCF growth 5Y-20.26%
OCF growth 1Y-59.08%
OCF growth 3Y-24.88%
OCF growth 5Y-19.94%